Through a risk model comprising 16 significant lipid metabolism genes as risk factors and comprehensive genomic and transcriptomic analyses coupled with functional assays, this research illuminates the prognostic significance of lipid metabolism genes in PCa and underscores SUCLG2’s potential as a therapeutic target. The gene discussed is SUCLG2; the disease is posterior cortical atrophy.